Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.

Yuta Aida, Hiroshi Abe, Yoichi Tomita, Tomohisa Nagano, Nobuyoshi Seki, Tomonori Sugita, Munenori Itagaki, Haruya Ishiguro, Satoshi Sutoh, Yoshio Aizawa

PubMed · 2014 · 35 citations · 30 references

Full text

Open access

Abstract

Serum CK18-F could be a clinically useful biomarker to discriminate between NAFL and NASH.

References

30